Cancers

Herausgeber

Mdpi

International Standard Serial Number (ISSN )

2072-6694

Electronic International Standard Serial Number ( EISSN )

2072-6694

ISSN gedruckt

2072-6694

URL

https://www.mdpi.com/journal/cancers

Weitere Details

2025

Loss of ING3 in the Prostate Leads to Activation of DNA Damage Repair Markers.

2024

Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [¹⁸F]FDG-PET/MRI

2024

Non-Contrast-Enhanced Multiparametric MRI of the Hypoxic Tumor Microenvironment Allows Molecular Subtyping of Breast Cancer: A Pilot Study

2024

Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer.

2023

Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma.

2022

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL

2022

CDK6 Degradation Is Counteracted by p16^INK4A and p18^INK4C in AML

2022

Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells

2022

Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.

2021

A recurrent STAT5B^N642H driver mutation in feline alimentary t cell lymphoma.

2021

Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD⁺ Acute Myeloid Leukemia

2021

Oncogenic kinase cascades induce molecular mechanisms that protect leukemic cell models from lethal effects of de novo dntp synthesis inhibition.

2021

Proteomic analysis identifies ndufs1 and atp5o as novel markers for survival outcome in prostate cancer.

2021

The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma

2021

Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

2020

Decoding the Role of CD271 in Melanoma.

2020

Loss of Ing3 Expression Results in Growth Retardation and Embryonic Death.

2020

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers

2020

STAT5 is Expressed in CD34⁺/CD38^- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

2020

TYK2 in Tumor Immunosurveillance

2020

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia

2020

Targeting STAT3 and STAT5 in Cancer

2020

The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray.

2019

A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions.

2019

Biological Functions of the ING Proteins

2019

Companion Animals as Models for Inhibition of STAT3 and STAT5.

2019

Direct Targeting Options for STAT3 and STAT5 in Cancer

2019

STAT3 and STAT5 Activation in Solid Cancers

2019

STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia

2019

STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice

2019

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations

2019

TYK2: An Upstream Kinase of STATs in Cancer

2018

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

2015

Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells.

2014

Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format

2025

Loss of ING3 in the Prostate Leads to Activation of DNA Damage Repair Markers.

2024

Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [¹⁸F]FDG-PET/MRI

2024

Non-Contrast-Enhanced Multiparametric MRI of the Hypoxic Tumor Microenvironment Allows Molecular Subtyping of Breast Cancer: A Pilot Study

2024

Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer.

2023

Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma.

2022

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL

2022

CDK6 Degradation Is Counteracted by p16^INK4A and p18^INK4C in AML

2022

Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells

2022

Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.

2021

A recurrent STAT5B^N642H driver mutation in feline alimentary t cell lymphoma.

2021

Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD⁺ Acute Myeloid Leukemia

2021

Oncogenic kinase cascades induce molecular mechanisms that protect leukemic cell models from lethal effects of de novo dntp synthesis inhibition.

2021

Proteomic analysis identifies ndufs1 and atp5o as novel markers for survival outcome in prostate cancer.

2021

The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma

2021

Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

2020

Decoding the Role of CD271 in Melanoma.

2020

Loss of Ing3 Expression Results in Growth Retardation and Embryonic Death.

2020

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers

2020

STAT5 is Expressed in CD34⁺/CD38^- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

2020

TYK2 in Tumor Immunosurveillance

2020

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia

2020

Targeting STAT3 and STAT5 in Cancer

2020

The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray.

2019

A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions.

2019

Biological Functions of the ING Proteins

2019

Companion Animals as Models for Inhibition of STAT3 and STAT5.

2019

Direct Targeting Options for STAT3 and STAT5 in Cancer

2019

STAT3 and STAT5 Activation in Solid Cancers

2019

STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia

2019

STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice

2019

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations

2019

TYK2: An Upstream Kinase of STATs in Cancer

2018

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

2015

Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells.

2014

Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format